Follow
Tamantha Stutchbury (nee Littlejohn)
Tamantha Stutchbury (nee Littlejohn)
Global Challenges Program, University of Wollongong
Verified email at uow.edu.au
Title
Cited by
Cited by
Year
The heme environment of recombinant human indoleamine 2, 3-dioxygenase: Structural properties and substrate-ligand interactions
AC Terentis, SR Thomas, O Takikawa, TK Littlejohn, RJW Truscott, ...
Journal of Biological Chemistry 277 (18), 15788-15794, 2002
1292002
Expression and purification of recombinant human indoleamine 2, 3-dioxygenase
TK Littlejohn, O Takikawa, D Skylas, JF Jamie, MJ Walker, RJW Truscott
Protein expression and purification 19 (1), 22-29, 2000
1132000
Asp274 and his346 are essential for heme binding and catalytic function of human indoleamine 2, 3-dioxygenase
TK Littlejohn, O Takikawa, RJW Truscott, MJ Walker
Journal of Biological Chemistry 278 (32), 29525-29531, 2003
952003
Induction of indolamine 2, 3-dioxygenase in primary human macrophages by human immunodeficiency virus type 1 is strain dependent
RS Grant, H Naif, SJ Thuruthyil, N Nasr, T Littlejohn, O Takikawa, ...
Journal of Virology 74 (9), 4110-4115, 2000
872000
Indoleamine 2, 3-dioxygenase in the human lens, the first enzyme in the synthesis of UV filters
O Takikawa, TK Littlejohn, RJW Truscott
Experimental eye research 72 (3), 271-277, 2001
672001
Inhibition of indoleamine 2, 3 dioxygenase activity by H2O2
A Poljak, R Grant, CJD Austin, JF Jamie, RD Willows, O Takikawa, ...
Archives of Biochemistry and Biophysics 450 (1), 9-19, 2006
462006
Induction of indoleamine 2, 3-dioxygenase in primary human macrophages by HIV-1
RS Grant, H Naif, SJ Thuruthyil, N Nasr, T Littlejohn, O Takikawa, ...
Redox Report 5 (2-3), 105-107, 2000
452000
Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma
TK Stutchbury, F Al-Ejeh, GE Stillfried, DR Croucher, J Andrews, D Irving, ...
Molecular Cancer Therapeutics 6 (1), 203-212, 2007
372007
Challenge-led interdisciplinary research in practice: Program design, early career research, and a dialogic approach to building unlikely collaborations
C Gibson, T Stutchbury, V Ikutegbe, N Michielin
Research Evaluation 28 (1), 51-62, 2019
262019
Regulation of Indoleamine 2, 3-Dioxygenase, The First Enzyme in Uv Filter Biosynthesis in the Human Lens: Relevance for Senile Nuclear Cataract
O Takikawa, T Littlejohn, JF Jamie, MJ Walker, RJW Truscott
Tryptophan, Serotonin, and Melatonin: Basic Aspects and Applications, 241-245, 1999
171999
Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles
TK Stutchbury, KL Vine, JM Locke, JS Chrisp, JB Bremner, PR Clingan, ...
Anti-Cancer Drugs 22 (1), 24-34, 2011
132011
Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate
JM Locke, TK Stutchbury, KL Vine, AB Gamble, PR Clingan, JB Bremner, ...
Anti-cancer drugs 20 (9), 822-831, 2009
102009
White paper: challenge-led interdisciplinary research programs
T Stutchbury, C Gibson, L Moxham, C Schofield, G Spinks
University of Wollongong Wollongong, Australia, 2015
52015
Understanding the assistive technology needs of people over 55: The future of mobility aids
LJ Moxham, TK Stutchbury, G Spinks, E de Vet, V Ikutegbe, V Traynor, ...
Australasian Journal on Ageing 38 (4), e127-e134, 2019
22019
Studies on human indoleamine 2, 3-dioxygenase (IDO)
TK Littlejohn
22001
Regulation of indoleamine 2, 3-dioxygenase, the first enzyme in UV filter biosynthesis in the human lens
O Takikawa¹, JFJ Tamantha Littlejohn, MJ Walker, RJW Truscott¹
Tryptophan, Serotonin, and Melatonin: Basic Aspects and Applications 467, 241, 2012
12012
Production of truncated enzymically active human indoleamine 2, 3-dioxygenase using site-directed mutagenesis
TK Littlejohn, O Takikawa, JF Jamie, MJ Walker, RJW Truscott
International Congress Series 1233, 157-160, 2002
12002
Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate
AB Gamble, J Locke, PR Clingan, T Stutchbury, JB Bremner, M Ranson, ...
Faculty of Science-Papers, 218, 2009
2009
Inhibition of Indoleamine 2, 3 Dioxygenase Activity by H2O2
GA Smythe, P Sachdev, MJ Walker, RJ Truscott, TK Littlejohn, O Takikawa, ...
2006
Indoleamine 2, 3-Dioxygenase-Structure and Ligand-Based Drug Design
CJD Austin, JF Jamie, R Willows, N Sirijovski, R Truscott, T Littlejohn, ...
The 39th IUPAC Congress and the 86th Conference of the Canadian Society for …, 2003
2003
The system can't perform the operation now. Try again later.
Articles 1–20